tm logo
MEDIDELIC
Live/Registered
REGISTERED

on 06 Feb 2024

Last Applicant/ Owned by

1324 East Desert Willow Drive

Phoenix

US

AZ

85048

Serial Number

90506292 filed on 03rd Feb 2021

Registration Number

7299931 registered on 06th Feb 2024

in the Principal Register

Correspondent Address

Dean H. Kayes

Dean H. Kayes

1028 N. LAKE AVE. SUITE 202

PASADENA CA 91104

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

MEDIDELIC

Biotechnology research; Research and development in the pharmaceutical, bioenergetic imprinting and biotechnology fields; Providing information on the subject of scientific research in the field of biochemistry, biological signaling and biotechnology; Development of new technology for others in the field of biotechnology; Scientific Research and Development of Absorption, Distribution, Metabolism, Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Biotechnology research; Research and development in the pharmaceutical, bioenergetic imprinting and biotechnology fields; Providing information on the subject of scientific research in the field of biochemistry, biological signaling and biotechnology; Development of new technology for others in the field of biotechnology; Scientific Research and Development of Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) modeling, physiologically based pharmacokinetic (PBPK) and physiologically based biopharmaceutics (PBBM) modeling and simulation software for the pharmaceutical and biotechnology industries; Research and Development of software that allows pharmaceutical scientists to predict certain key potential endpoints and dynamics, in silico, thereby reducing research and development costs and helping clients make better projects decisions sooner that includes PBBK (Physical based pharmacokinetics), PBBM (Physiologically based biopharmaceutics), NOAEL (No observed adverse effect level); Scientific Research and Development utilizing a proprietary algorithm and artificial intelligence that utilizes a combination of lifestyle, hospitalization, emergency room use, mortality and outcomes data to assist the healthcare industry and workers in identifying groups at high risk and populations that can benefit from various therapeutic approaches; Scientific Research and Development of drugs and therapies through applying interactive maps that identify ideal target populations for various therapeutic approaches including the mapping of surfaces that apply socio, economic and environmental factors such as access to or lack of access to transportation or nutritious food, or exposure to high stress and artificial intelligence analysis considering the suitability of various drugs or therapies


First Use Date in General

28th Nov 2022

First Use Date in Commerce

28th Nov 2022

Specimens


MEDIDELIC specimenMEDIDELIC specimenMEDIDELIC specimenMEDIDELIC specimenMEDIDELIC specimenMEDIDELIC specimenMEDIDELIC specimenMEDIDELIC specimenMEDIDELIC specimenMEDIDELIC specimenMEDIDELIC specimenMEDIDELIC specimen

Mark Details


Serial Number

No 90506292

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
06th Feb 2024REGISTERED-PRINCIPAL REGISTER
06th Feb 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
03rd Jan 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02th Jan 2024ELECTRONIC RECORD REVIEW COMPLETE
22nd Dec 2023ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
20th Dec 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
19th Dec 2023SU-EXAMINER'S AMENDMENT WRITTEN
19th Dec 2023EXAMINERS AMENDMENT E-MAILED
19th Dec 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
19th Dec 2023EXAMINER'S AMENDMENT ENTERED